Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Laboratoires FILL-MED and Novacap Select Veeva to Drive Greater Agility in Quality Management

Veeva Systems
Posted on: 13 Nov 18

Veeva Systems (NYSE:VEEV), a provider of quality and regulatory cloud software for the consumer goods, cosmetics, chemical, and life sciences industries, today announced Laboratoires FILL-MED, a Filorga Group company, and Novacap are adopting Veeva QualityOne to modernize quality management. QualityOne allows organizations to manage quality processes, document control, and data in a single application. Leading chemical and cosmetics companies can now implement agile quality processes to ensure ongoing compliance and improve collaboration.

Laboratoires FILL-MED is a fast-growing French company that specializes in developing innovative medical devices for aesthetic medicine. The company will use QualityOne to stay ahead of evolving standards and maintain audit readiness.

“Veeva QualityOne is essential to our strategy of making quality and innovation two key pillars of the company,” said Christophe Foucher, CEO of Laboratoires FILL-MED. “We will have greater flexibility in maintaining quality and drive greater efficiency in product development.”

Novacap is a leading raw materials supplier and contract manufacturing organization for the pharmaceutical and cosmetics markets. QualityOne provides Novacap the foundation to closely collaborate with their customers and achieve GMP and FDA regulatory compliance.

“Veeva has demonstrated its broad range of capabilities in the highly regulated pharmaceutical industry over the past 10 years,” said Alexandre Gultzgoff, CIO of Novacap. “The company’s reputation, proven cloud solutions, and commitment to meeting our industry requirements were important factors in our decision to select Veeva. Veeva will help us unify people, processes, and data across the organization.”

QualityOne is helping cosmetics and chemical companies deliver continuous improvement on quality from product development to manufacturing and in-market claims. With more than 30 customers, QualityOne continues to gain momentum by providing a unified, easy-to-use cloud application for organizations to modernize quality management and document control.

“Leading companies are recognizing that a more agile approach is needed to manage the product journey,” said Frank Defesche, SVP and GM at Veeva. “QualityOne is fulfilling pent-up industry demand in North America and Europe for an innovative quality management solution. We look forward to helping more chemical and cosmetics companies modernize their quality processes.”

Join Veeva at the Congrès Parfums & Cosmétiques event, Nov. 14-15, in Chartres, France to learn more about QualityOne. For more information, visit veeva.com/CosmeticsEvents.

Additional Information

For more information on QualityOne, visit: veeva.com/QualityOne

Connect with Veeva on LinkedIn: linkedin.com/company/qualityone

Follow @veevaindustries on Twitter: twitter.com/veevaindustries

Like Veeva on Facebook: facebook.com/veevaindustries

About Veeva Systems

Founded in 2007, Veeva (NYSE:VEEV) is a global provider of industry-specific, cloud-based software solutions for the consumer goods, cosmetics, chemical, and life sciences industries. Our applications enable manufacturers to realize the benefits of a modern, cloud-based platform to manage the product journey and bring innovative, high-quality products to market faster without compromising industry-specific functionality, quality, or regulatory compliance. Veeva is headquartered in the San Francisco Bay Area, with offices throughout North America, Europe, Asia, and Latin America. Learn more at www.industries.veeva.com.

Forward-looking Statements

This release contains forward-looking statements, including the market demand for and acceptance of Veeva’s products and services, the results from use of Veeva’s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva’s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva’s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva’s financial results are included under the captions, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in the company’s filing on Form 10-Q for the period ended July 31, 2018. This is available on the company’s website at veeva.com under the Investors section and on the SEC’s website at sec.gov. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181113006125/en/

Business Wire
www.businesswire.com

Last updated on: 13/11/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.